Shilpa Medicare Commissions Integrated ADC Drug Substance GMP Manufacturing Facility

Shilpa Biologicals commissioned one of India's few integrated Antibody-Drug Conjugate GMP manufacturing facilities, designed to meet US FDA and EMA standards, positioning Shilpa Medicare as a cost-competitive CDMO partner for global oncology ADC drug substance manufacturing.